Melissa Hollo: How HerCare Utilizes Hierarchical Algorithm of Severe Maternal Morbidity
Melissa Hollo, Director of Project Management at hc1 and Licensed Independent Clinical Social Worker, shared a post on LinkedIn:
“A recent study titled ‘Hierarchical algorithm identifies methods of severe maternal morbidity’ by Joshua Fitch, Senior Editor, published in Obstetrics and Gynecology, highlights a significant advancement in our understanding of severe maternal morbidity.
The study emphasizes the need for earlier and more precise identification of risks.
The research introduces a hierarchical algorithm that achieves a 94.5% concordance with manual chart reviews in identifying the primary drivers of maternal morbidity.
Key findings indicate that hemorrhage, hypertension, and infection are major contributors to maternal complications, with hypertension and infection alone responsible for nearly 45% of non-transfusion related cases.
While this study provides clarity on the factors driving maternal morbidity, it also highlights a critical gap in care: risks are often identified only after they have escalated.
At hc1, we are addressing this issue through HerCare.
HerCare utilizes a hierarchical, data-driven approach to identify maternal risk earlier in the care journey, before complications become severe.
By integrating clinical, lab, and longitudinal patient data, we empower providers to proactively detect risks such as iron deficiency, hypertensive disorders, and infections – conditions that significantly contribute to morbidity.
The opportunity lies not just in better classification, but in intervention.
By identifying these risks sooner, we can:
- Improve maternal outcomes and reduce preventable complications
- Decrease costly acute interventions and hospital utilization
- Close the gap between morbidity and mortality drivers through earlier care pathways
We can begin to shift the curve on maternal health by combining clinical insight with actionable intelligence at the point of care.
Learn how we’re supporting earlier maternal risk detection.”
More posts featuring Melissa Hollo on Hemostasis Today.
-
May 7, 2026, 07:21Britta Diebel: Reflections on Healthcare Impact from the PPTA IPPC Congress
-
May 7, 2026, 07:02Ana Cláudia de Souza: NeuroLeadership, Management and Behavioural Insights in Stroke Care from ESOC 2026
-
May 7, 2026, 07:00Maxime Dely: Just 60 Minutes of Our Time to Help a Patient We Will Never Meet
-
May 7, 2026, 06:37Anagha Kulkarni: Insights and A Prize from ISBMT Annual Conference 2026
-
May 7, 2026, 06:37Neelmani Singh: Why Iron Deficiency Is a Brain Health Issue
-
May 7, 2026, 06:25Vivek Sinha: The Science Behind a CBC Test
-
May 7, 2026, 06:17Emily Brown: Honor to Represent Hemophilia of Georgia at 2026 World Federation of Hemophilia Congress
-
May 7, 2026, 06:08Abdelaziz Fahem: INNOVHEM Reports a New Direct Method for Evaluating Hemolytic Anemia
-
May 7, 2026, 06:02Derick Rugenga: Every Person Living with Haemophilia Deserves to Live Without Fear